Zhejiang Shouxiangu Pharm Co (603896) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Zhejiang Shouxiangu Pharm Co (603896) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.94 Million ≈ $3.06 Million USD) by net assets (CN¥2.31 Billion ≈ $338.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Zhejiang Shouxiangu Pharm Co for the company's overall valuation and market capitalisation.

Zhejiang Shouxiangu Pharm Co - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Zhejiang Shouxiangu Pharm Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Shouxiangu Pharm Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Shouxiangu Pharm Co ranked by their cash flow conversion efficiency. Explore Zhejiang Shouxiangu Pharm Co (603896) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SuZhou ChunXing Precision Mechanical Co Ltd SHE:002547	0.021x
Magnera Corp placeholder NYSE:MAGN	-0.013x
HANSEN TECHNOLOGIES LTD. F:H2T	N/A
Eik fasteignafélag hf IC:EIK	0.017x
Electra Real Estate Ltd TA:ELCRE	0.009x
Carlsmed, Inc. NASDAQ:CARL	-0.087x
Codere Online US Corp NASDAQ:CDRO	0.135x
TIDEWATER RENEWABLES LTD F:7GZ	0.135x

Annual Cash Flow Conversion Efficiency for Zhejiang Shouxiangu Pharm Co (2012–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Shouxiangu Pharm Co from 2012 to 2025. View latest Zhejiang Shouxiangu Pharm Co stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.26 Billion ≈ $330.77 Million	CN¥228.07 Million ≈ $33.37 Million	0.101x	+8.44%
2024-12-31	CN¥2.29 Billion ≈ $335.69 Million	CN¥213.44 Million ≈ $31.23 Million	0.093x	-35.88%
2023-12-31	CN¥2.17 Billion ≈ $317.73 Million	CN¥315.06 Million ≈ $46.10 Million	0.145x	-18.98%
2022-12-31	CN¥1.91 Billion ≈ $278.84 Million	CN¥341.28 Million ≈ $49.94 Million	0.179x	-2.21%
2021-12-31	CN¥1.62 Billion ≈ $237.06 Million	CN¥296.70 Million ≈ $43.42 Million	0.183x	-5.25%
2020-12-31	CN¥1.33 Billion ≈ $194.08 Million	CN¥256.36 Million ≈ $37.51 Million	0.193x	+9.00%
2019-12-31	CN¥1.17 Billion ≈ $171.57 Million	CN¥207.92 Million ≈ $30.42 Million	0.177x	+1.82%
2018-12-31	CN¥984.74 Million ≈ $144.10 Million	CN¥171.51 Million ≈ $25.10 Million	0.174x	+36.71%
2017-12-31	CN¥869.75 Million ≈ $127.27 Million	CN¥110.80 Million ≈ $16.21 Million	0.127x	-41.72%
2016-12-31	CN¥436.93 Million ≈ $63.94 Million	CN¥95.52 Million ≈ $13.98 Million	0.219x	-5.25%
2015-12-31	CN¥368.53 Million ≈ $53.93 Million	CN¥85.03 Million ≈ $12.44 Million	0.231x	-28.12%
2014-12-31	CN¥320.56 Million ≈ $46.91 Million	CN¥102.90 Million ≈ $15.06 Million	0.321x	+45.99%
2013-12-31	CN¥299.50 Million ≈ $43.83 Million	CN¥65.85 Million ≈ $9.64 Million	0.220x	-32.93%
2012-12-31	CN¥138.37 Million ≈ $20.25 Million	CN¥45.36 Million ≈ $6.64 Million	0.328x	--

About Zhejiang Shouxiangu Pharm Co

SHG:603896 China Biotechnology

Market Cap

$409.32 Million

CN¥2.80 Billion CNY

Market Cap Rank

#13407 Global

#4006 in China

Share Price

CN¥14.11

Change (1 day)

+0.79%

52-Week Range

CN¥12.95 - CN¥22.30

All Time High

CN¥56.07